QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CERS

QT72Cerus Corporation
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
2.70
+0.13+5.06%
OverviewShort InterestFilings
CERSQT72Cerus Corporation·NASDAQ
OverviewShort InterestFilings
2.70+5.06%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-0.10
Insider Own8.25%
Shs Outstand200.37M
Perf Week4.25%
Market Cap514.95MForward P/E-EPS next Y0.00Insider Trans-0.65%Shs Float-Perf Month0.00%
Enterprise Value584.46MPEG-EPS next Q-Inst Own-Short Float-Perf Quarter53.41%
Income-9835512.00P/S2.31EPS this Y66.67%Inst Trans-Short Ratio-Perf Half Y25.00%
Sales222.79MP/B7.39EPS next Y90.00%ROA-4.28%Short Interest-Perf YTD31.07%
Book/sh0.34P/C189.57EPS next 5Y-ROE-15.36%52W High3.15 -14.29%Perf Year106.11%
Cash/sh0.40P/FCF-EPS past 3/5Y-ROIC-10.34%52W Low1.15 134.78%Perf 3Y-
Dividend Est.-EV/EBITDA491.14Sales past 3/5Y8.34% 17.49%Gross Margin54.31%Volatility5.04% 4.08%Perf 5Y-
Dividend TTM-EV/Sales2.62EPS Y/Y TTM-Oper. Margin-7.94%ATR (14)0.18Perf 10Y-
Dividend Ex-Date-Quick Ratio1.06Sales Y/Y TTM6.67%Profit Margin-4.29%RSI (14)55.73Recom2.20
Dividend Gr. 3/5Y-Current Ratio1.63EPS Q/Q-SMA200.35%Beta1.71Target Price4.00
Payout0.00%Debt/Eq1.44Sales Q/Q39.53%SMA5011.09%Rel Volume1.32Prev Close2.57
Employees614LT Debt/Eq0.78Earnings-SMA20034.31%Avg Volume2.49MPrice2.70
IPO DateJan 31, 1997Option/ShortNo / YesEPS/Sales Surpr.-Net Debt/EBITDA58.41Volume3,293,077Change5.06%
Analyst Ratings
DateActionAnalystRatingTarget
May-01-26UpgradeBTIGNeutral → Buy$4.00
Oct-17-24ReiteratedStifel Nicolaus$3.00
May-03-24ReiteratedCantor FitzgeraldOverweight$4.00
Apr-12-24ReiteratedCraig-Hallum$5.00
Jan-20-23DowngradeBTIGBuy → Neutral
Nov-13-19UpgradeBTIGNeutral → Buy
Nov-13-19UpgradeBTIG ResearchNeutral → Buy
Dec-17-15DowngradeWedbushOutperform → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue192206180
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A849681
Gross Profit107110100
Selling, General and Administrative Excl. Other788176
Research and Development656659
Other Operating Expense-100-21
Operating Income-24-36-14
Interest Expense889
Unusual Expense
———
Non-Operating Income (Expense)-15-29-2
Net Income Before Taxes-19-15-21
Income Taxes
000
Consolidated Net Income-20-16-21
Net Income From Continuing Operations-20-16-21
Net Income-20-16-21
EPS (Recurring)-0.10-0.08-0.11
EPS (Basic, Before Extraordinaries)-0.10-0.08-0.11
EPS (Diluted)-0.10-0.08-0.11
EBITDA-8-5-10
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.691.91—
Gross Margin55.7353.4055.56
Operating Margin-12.50-17.48-7.78
Net Margin-10.42-7.77-11.67
Shares Outstanding191191185
Market Capitalization516393—
Operating Lease Expense
———
Insider Trading Volume
$2.92$2.70$2.48$2.27$2.05● Close Price0.00M0.56M1.11M1.67M2.23MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BJERKHOLT ERICDirectorJun 09 '26Sale2.6020,45453,180261,679Jun 11 12:00 AM
Jayaraman Vivek KChief Operating OfficerMay 29 '26Sale3.0016,66750,0011,656,707Jun 02 12:00 AM
Jayaraman Vivek KChief Operating OfficerMay 01 '26Sale3.0016,66750,0011,673,374May 05 12:00 AM
Green Kevin DennisChief Financial OfficerMar 12 '26Sale1.66127,544211,3661,040,551Mar 16 12:00 AM
Jayaraman Vivek KChief Operating OfficerMar 12 '26Sale1.66165,200273,7691,747,674Mar 16 12:00 AM
Greenman William MarinerPresident and CEOMar 12 '26Sale1.66447,757742,0234,998,493Mar 16 12:00 AM
Benjamin Richard JChief Medical OfficerMar 12 '26Sale1.66101,740168,604777,361Mar 16 12:00 AM
Jensen ChrystalChief Legal OfficerMar 12 '25Sale1.66113,008187,277946,131Mar 16 12:00 AM
Benjamin Richard JChief Medical OfficerMar 05 '26Sale2.06122,466252,604943,762Mar 10 12:00 AM
Benjamin Richard JChief Medical OfficerMar 09 '26Sale1.8840,42676,029879,101Mar 09 12:00 AM
Benjamin Richard JChief Medical OfficerMar 06 '26Sale2.0124,23548,603919,527Mar 09 12:00 AM
Green Kevin DennisChief Financial OfficerMar 06 '26Sale2.0127,79655,7451,168,095Mar 09 12:00 AM
Jensen ChrystalChief Legal OfficerMar 06 '26Sale2.0130,84561,8601,059,139Mar 09 12:00 AM
Jayaraman Vivek KChief Operating OfficerMar 06 '26Sale2.0134,09468,3761,912,874Mar 09 12:00 AM
Greenman William MarinerPresident and CEOMar 06 '26Sale2.0178,187156,8045,446,250Mar 09 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR